nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—TP53—schizophrenia	0.582	0.857	CbGaD
Acetylsalicylic acid—ABCB1—schizophrenia	0.0968	0.143	CbGaD
Acetylsalicylic acid—HSPA5—pineal body—schizophrenia	0.00794	0.0778	CbGeAlD
Acetylsalicylic acid—HSPA5—blood plasma—schizophrenia	0.00436	0.0428	CbGeAlD
Acetylsalicylic acid—TP53—forebrain—schizophrenia	0.00248	0.0243	CbGeAlD
Acetylsalicylic acid—CYP2C19—urine—schizophrenia	0.00247	0.0242	CbGeAlD
Acetylsalicylic acid—NFKBIA—forebrain—schizophrenia	0.00244	0.0239	CbGeAlD
Acetylsalicylic acid—HSPA5—forebrain—schizophrenia	0.00239	0.0234	CbGeAlD
Acetylsalicylic acid—TP53—telencephalon—schizophrenia	0.00228	0.0224	CbGeAlD
Acetylsalicylic acid—NFKBIA—telencephalon—schizophrenia	0.00224	0.022	CbGeAlD
Acetylsalicylic acid—HSPA5—telencephalon—schizophrenia	0.0022	0.0215	CbGeAlD
Acetylsalicylic acid—RPS6KA3—forebrain—schizophrenia	0.00204	0.02	CbGeAlD
Acetylsalicylic acid—CYP2C9—urine—schizophrenia	0.00192	0.0188	CbGeAlD
Acetylsalicylic acid—TP53—gonad—schizophrenia	0.0019	0.0187	CbGeAlD
Acetylsalicylic acid—NFKBIA—gonad—schizophrenia	0.00187	0.0184	CbGeAlD
Acetylsalicylic acid—RPS6KA3—telencephalon—schizophrenia	0.00187	0.0183	CbGeAlD
Acetylsalicylic acid—HSPA5—gonad—schizophrenia	0.00183	0.018	CbGeAlD
Acetylsalicylic acid—TP53—blood—schizophrenia	0.00166	0.0163	CbGeAlD
Acetylsalicylic acid—NFKBIA—blood—schizophrenia	0.00163	0.016	CbGeAlD
Acetylsalicylic acid—NFKBIA—midbrain—schizophrenia	0.00161	0.0158	CbGeAlD
Acetylsalicylic acid—HSPA5—blood—schizophrenia	0.0016	0.0157	CbGeAlD
Acetylsalicylic acid—HSPA5—midbrain—schizophrenia	0.00158	0.0155	CbGeAlD
Acetylsalicylic acid—TP53—endocrine gland—schizophrenia	0.00144	0.0141	CbGeAlD
Acetylsalicylic acid—NFKBIA—endocrine gland—schizophrenia	0.00142	0.0139	CbGeAlD
Acetylsalicylic acid—HSPA5—endocrine gland—schizophrenia	0.00139	0.0136	CbGeAlD
Acetylsalicylic acid—IKBKB—telencephalon—schizophrenia	0.00138	0.0135	CbGeAlD
Acetylsalicylic acid—RPS6KA3—blood—schizophrenia	0.00136	0.0133	CbGeAlD
Acetylsalicylic acid—TP53—nervous system—schizophrenia	0.00135	0.0132	CbGeAlD
Acetylsalicylic acid—RPS6KA3—midbrain—schizophrenia	0.00134	0.0132	CbGeAlD
Acetylsalicylic acid—NFKBIA—nervous system—schizophrenia	0.00133	0.013	CbGeAlD
Acetylsalicylic acid—HSPA5—nervous system—schizophrenia	0.0013	0.0127	CbGeAlD
Acetylsalicylic acid—TP53—central nervous system—schizophrenia	0.0013	0.0127	CbGeAlD
Acetylsalicylic acid—CYP2C19—blood plasma—schizophrenia	0.00129	0.0126	CbGeAlD
Acetylsalicylic acid—NFKBIA—central nervous system—schizophrenia	0.00128	0.0125	CbGeAlD
Acetylsalicylic acid—TP53—cerebellum—schizophrenia	0.00127	0.0124	CbGeAlD
Acetylsalicylic acid—HSPA5—central nervous system—schizophrenia	0.00125	0.0122	CbGeAlD
Acetylsalicylic acid—NFKBIA—cerebellum—schizophrenia	0.00125	0.0122	CbGeAlD
Acetylsalicylic acid—HSPA5—cerebellum—schizophrenia	0.00122	0.012	CbGeAlD
Acetylsalicylic acid—RPS6KA3—endocrine gland—schizophrenia	0.00118	0.0116	CbGeAlD
Acetylsalicylic acid—IKBKB—gonad—schizophrenia	0.00115	0.0113	CbGeAlD
Acetylsalicylic acid—CYP2C8—blood plasma—schizophrenia	0.00113	0.011	CbGeAlD
Acetylsalicylic acid—RPS6KA3—nervous system—schizophrenia	0.00111	0.0108	CbGeAlD
Acetylsalicylic acid—EDNRA—midbrain—schizophrenia	0.00109	0.0107	CbGeAlD
Acetylsalicylic acid—RPS6KA3—central nervous system—schizophrenia	0.00106	0.0104	CbGeAlD
Acetylsalicylic acid—RPS6KA3—cerebellum—schizophrenia	0.00104	0.0102	CbGeAlD
Acetylsalicylic acid—TP53—brain—schizophrenia	0.00103	0.0101	CbGeAlD
Acetylsalicylic acid—NFKBIA—brain—schizophrenia	0.00101	0.00993	CbGeAlD
Acetylsalicylic acid—IKBKB—blood—schizophrenia	0.00101	0.00985	CbGeAlD
Acetylsalicylic acid—CYP2C9—blood plasma—schizophrenia	0.001	0.0098	CbGeAlD
Acetylsalicylic acid—HSPA5—brain—schizophrenia	0.000992	0.00972	CbGeAlD
Acetylsalicylic acid—PTGS1—blood plasma—schizophrenia	0.000913	0.00895	CbGeAlD
Acetylsalicylic acid—PTGS2—blood plasma—schizophrenia	0.000873	0.00855	CbGeAlD
Acetylsalicylic acid—IKBKB—endocrine gland—schizophrenia	0.000872	0.00854	CbGeAlD
Acetylsalicylic acid—SLC22A7—endocrine gland—schizophrenia	0.000846	0.00829	CbGeAlD
Acetylsalicylic acid—RPS6KA3—brain—schizophrenia	0.000845	0.00828	CbGeAlD
Acetylsalicylic acid—IKBKB—nervous system—schizophrenia	0.000816	0.008	CbGeAlD
Acetylsalicylic acid—IKBKB—central nervous system—schizophrenia	0.000786	0.0077	CbGeAlD
Acetylsalicylic acid—IKBKB—cerebellum—schizophrenia	0.000768	0.00753	CbGeAlD
Acetylsalicylic acid—EDNRA—brain—schizophrenia	0.000687	0.00673	CbGeAlD
Acetylsalicylic acid—IKBKB—brain—schizophrenia	0.000624	0.00611	CbGeAlD
Acetylsalicylic acid—SLC22A7—brain—schizophrenia	0.000605	0.00593	CbGeAlD
Acetylsalicylic acid—SLC22A6—brain—schizophrenia	0.000584	0.00572	CbGeAlD
Acetylsalicylic acid—ABCB1—blood plasma—schizophrenia	0.00054	0.00529	CbGeAlD
Acetylsalicylic acid—PTGS1—forebrain—schizophrenia	0.0005	0.0049	CbGeAlD
Acetylsalicylic acid—PTGS2—forebrain—schizophrenia	0.000478	0.00468	CbGeAlD
Acetylsalicylic acid—CYP2C19—blood—schizophrenia	0.000472	0.00463	CbGeAlD
Acetylsalicylic acid—PTGS1—telencephalon—schizophrenia	0.00046	0.00451	CbGeAlD
Acetylsalicylic acid—PTGS2—telencephalon—schizophrenia	0.00044	0.00431	CbGeAlD
Acetylsalicylic acid—CYP2C8—blood—schizophrenia	0.000412	0.00404	CbGeAlD
Acetylsalicylic acid—CYP2C19—endocrine gland—schizophrenia	0.00041	0.00402	CbGeAlD
Acetylsalicylic acid—CYP2C9—blood—schizophrenia	0.000366	0.00359	CbGeAlD
Acetylsalicylic acid—ALB—brain—schizophrenia	0.000364	0.00357	CbGeAlD
Acetylsalicylic acid—CYP2C8—endocrine gland—schizophrenia	0.000358	0.0035	CbGeAlD
Acetylsalicylic acid—PTGS1—blood—schizophrenia	0.000334	0.00328	CbGeAlD
Acetylsalicylic acid—PTGS2—blood—schizophrenia	0.00032	0.00313	CbGeAlD
Acetylsalicylic acid—CYP2C9—endocrine gland—schizophrenia	0.000318	0.00311	CbGeAlD
Acetylsalicylic acid—PTGS2—midbrain—schizophrenia	0.000316	0.00309	CbGeAlD
Acetylsalicylic acid—ABCB1—forebrain—schizophrenia	0.000296	0.0029	CbGeAlD
Acetylsalicylic acid—PTGS1—endocrine gland—schizophrenia	0.00029	0.00284	CbGeAlD
Acetylsalicylic acid—PTGS2—endocrine gland—schizophrenia	0.000277	0.00272	CbGeAlD
Acetylsalicylic acid—ABCB1—telencephalon—schizophrenia	0.000272	0.00266	CbGeAlD
Acetylsalicylic acid—PTGS1—nervous system—schizophrenia	0.000271	0.00266	CbGeAlD
Acetylsalicylic acid—PTGS1—central nervous system—schizophrenia	0.000261	0.00256	CbGeAlD
Acetylsalicylic acid—PTGS2—nervous system—schizophrenia	0.00026	0.00254	CbGeAlD
Acetylsalicylic acid—CYP2C8—brain—schizophrenia	0.000256	0.00251	CbGeAlD
Acetylsalicylic acid—PTGS2—central nervous system—schizophrenia	0.00025	0.00245	CbGeAlD
Acetylsalicylic acid—PTGS2—cerebellum—schizophrenia	0.000244	0.00239	CbGeAlD
Acetylsalicylic acid—ABCB1—gonad—schizophrenia	0.000227	0.00222	CbGeAlD
Acetylsalicylic acid—PTGS1—brain—schizophrenia	0.000208	0.00203	CbGeAlD
Acetylsalicylic acid—PTGS2—brain—schizophrenia	0.000198	0.00194	CbGeAlD
Acetylsalicylic acid—ABCB1—blood—schizophrenia	0.000198	0.00194	CbGeAlD
Acetylsalicylic acid—ABCB1—midbrain—schizophrenia	0.000195	0.00191	CbGeAlD
Acetylsalicylic acid—ABCB1—endocrine gland—schizophrenia	0.000171	0.00168	CbGeAlD
Acetylsalicylic acid—ABCB1—nervous system—schizophrenia	0.000161	0.00157	CbGeAlD
Acetylsalicylic acid—ABCB1—central nervous system—schizophrenia	0.000155	0.00151	CbGeAlD
Acetylsalicylic acid—ABCB1—cerebellum—schizophrenia	0.000151	0.00148	CbGeAlD
Acetylsalicylic acid—ABCB1—brain—schizophrenia	0.000123	0.0012	CbGeAlD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	8.61e-06	3.93e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PRKD1—schizophrenia	8.58e-06	3.92e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—TPH2—schizophrenia	8.55e-06	3.91e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CACNB2—schizophrenia	8.55e-06	3.91e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	8.55e-06	3.91e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NTRK2—schizophrenia	8.51e-06	3.89e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—DRD3—schizophrenia	8.47e-06	3.87e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—schizophrenia	8.47e-06	3.87e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—ABCB1—schizophrenia	8.43e-06	3.85e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—DPYD—schizophrenia	8.41e-06	3.84e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP26B1—schizophrenia	8.38e-06	3.83e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—DRD4—schizophrenia	8.23e-06	3.76e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—TPH1—schizophrenia	8.19e-06	3.74e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GCLM—schizophrenia	8.19e-06	3.74e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—SNAP25—schizophrenia	8.16e-06	3.73e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—AKT1—schizophrenia	8e-06	3.66e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—TPH1—schizophrenia	8e-06	3.66e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GCLM—schizophrenia	8e-06	3.66e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—EP300—schizophrenia	7.99e-06	3.65e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CNR1—schizophrenia	7.85e-06	3.59e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CACNA1C—schizophrenia	7.82e-06	3.57e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CYP1A2—schizophrenia	7.79e-06	3.56e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	7.73e-06	3.53e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PRKD1—schizophrenia	7.7e-06	3.52e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—APOA1—schizophrenia	7.69e-06	3.51e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—TH—schizophrenia	7.67e-06	3.51e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HTR7—schizophrenia	7.66e-06	3.5e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—DRD2—schizophrenia	7.66e-06	3.5e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3C2A—schizophrenia	7.62e-06	3.48e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—EP300—schizophrenia	7.55e-06	3.45e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PRKD1—schizophrenia	7.52e-06	3.44e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—TPH1—schizophrenia	7.47e-06	3.41e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GCLM—schizophrenia	7.47e-06	3.41e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HSPA1A—schizophrenia	7.33e-06	3.35e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NOS1—schizophrenia	7.27e-06	3.32e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PRL—schizophrenia	7.24e-06	3.31e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	7.22e-06	3.3e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GAPDH—schizophrenia	7.2e-06	3.29e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GAPDH—schizophrenia	7.16e-06	3.27e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CLOCK—schizophrenia	7.14e-06	3.26e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—APOE—schizophrenia	7.12e-06	3.25e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CLOCK—schizophrenia	7.1e-06	3.24e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—APOE—schizophrenia	7.08e-06	3.24e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	7.04e-06	3.22e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	7.04e-06	3.22e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PRKD1—schizophrenia	7.02e-06	3.21e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	7e-06	3.2e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—TPH2—schizophrenia	6.96e-06	3.18e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CACNB2—schizophrenia	6.96e-06	3.18e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—TPH2—schizophrenia	6.92e-06	3.16e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CACNB2—schizophrenia	6.92e-06	3.16e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—AKT1—schizophrenia	6.89e-06	3.15e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—schizophrenia	6.87e-06	3.14e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—DPYD—schizophrenia	6.84e-06	3.13e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—SNAP25—schizophrenia	6.84e-06	3.12e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CYP2D6—schizophrenia	6.84e-06	3.12e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—DPYD—schizophrenia	6.81e-06	3.11e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PRL—schizophrenia	6.75e-06	3.09e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—S100B—schizophrenia	6.74e-06	3.08e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—GSK3B—schizophrenia	6.68e-06	3.05e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—APOA1—schizophrenia	6.66e-06	3.04e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—FOS—schizophrenia	6.64e-06	3.03e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—COMT—schizophrenia	6.53e-06	2.98e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—GSTP1—schizophrenia	6.49e-06	2.97e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—MAOA—schizophrenia	6.48e-06	2.96e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ERBB4—schizophrenia	6.45e-06	2.95e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—AKT1—schizophrenia	6.44e-06	2.94e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GAPDH—schizophrenia	6.43e-06	2.94e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—EP300—schizophrenia	6.4e-06	2.92e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CLOCK—schizophrenia	6.37e-06	2.91e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CACNA1C—schizophrenia	6.36e-06	2.91e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—APOE—schizophrenia	6.36e-06	2.91e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CACNA1C—schizophrenia	6.33e-06	2.89e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—EP300—schizophrenia	6.32e-06	2.89e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	6.28e-06	2.87e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—schizophrenia	6.28e-06	2.87e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GAPDH—schizophrenia	6.28e-06	2.87e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CLOCK—schizophrenia	6.22e-06	2.84e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—TPH2—schizophrenia	6.21e-06	2.84e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CACNB2—schizophrenia	6.21e-06	2.84e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3C2A—schizophrenia	6.2e-06	2.83e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CYP1A2—schizophrenia	6.18e-06	2.83e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3C2A—schizophrenia	6.17e-06	2.82e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—ABCB1—schizophrenia	6.15e-06	2.81e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—DPYD—schizophrenia	6.11e-06	2.79e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—TH—schizophrenia	6.09e-06	2.78e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PLA2G4A—schizophrenia	6.06e-06	2.77e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—TPH2—schizophrenia	6.06e-06	2.77e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CACNB2—schizophrenia	6.06e-06	2.77e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	6.06e-06	2.77e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ERBB4—schizophrenia	6.02e-06	2.75e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—AKT1—schizophrenia	5.98e-06	2.73e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PLA2G4A—schizophrenia	5.97e-06	2.73e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—GSTM1—schizophrenia	5.97e-06	2.73e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—DPYD—schizophrenia	5.96e-06	2.73e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NRG1—schizophrenia	5.95e-06	2.72e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MEF2C—schizophrenia	5.9e-06	2.7e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GAPDH—schizophrenia	5.86e-06	2.68e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—AKT1—schizophrenia	5.85e-06	2.67e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—AKT1—schizophrenia	5.85e-06	2.67e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—APOA1—schizophrenia	5.83e-06	2.67e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CLOCK—schizophrenia	5.81e-06	2.66e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—APOE—schizophrenia	5.8e-06	2.65e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—AKT1—schizophrenia	5.77e-06	2.64e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	5.73e-06	2.62e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—EP300—schizophrenia	5.72e-06	2.61e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—EP300—schizophrenia	5.72e-06	2.61e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TP53—schizophrenia	5.72e-06	2.61e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—YWHAZ—schizophrenia	5.7e-06	2.61e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CACNA1C—schizophrenia	5.68e-06	2.6e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—TPH2—schizophrenia	5.66e-06	2.59e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CACNB2—schizophrenia	5.66e-06	2.59e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ERBB3—schizophrenia	5.58e-06	2.55e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—DPYD—schizophrenia	5.57e-06	2.55e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CYP2D6—schizophrenia	5.56e-06	2.54e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—SNAP25—schizophrenia	5.56e-06	2.54e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NRG1—schizophrenia	5.55e-06	2.54e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CACNA1C—schizophrenia	5.54e-06	2.53e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3C2A—schizophrenia	5.53e-06	2.53e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CYP2D6—schizophrenia	5.53e-06	2.53e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—SNAP25—schizophrenia	5.53e-06	2.53e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3C2A—schizophrenia	5.4e-06	2.47e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HTR2A—schizophrenia	5.37e-06	2.45e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—AKT1—schizophrenia	5.34e-06	2.44e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—YWHAZ—schizophrenia	5.32e-06	2.43e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—MTHFR—schizophrenia	5.27e-06	2.41e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ERBB3—schizophrenia	5.2e-06	2.38e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—AKT1—schizophrenia	5.2e-06	2.38e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—COMT—schizophrenia	5.18e-06	2.37e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CACNA1C—schizophrenia	5.18e-06	2.37e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GSTP1—schizophrenia	5.16e-06	2.36e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—MAOA—schizophrenia	5.14e-06	2.35e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	5.12e-06	2.34e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3C2A—schizophrenia	5.05e-06	2.31e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CYP1A2—schizophrenia	5.03e-06	2.3e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CYP1A2—schizophrenia	5e-06	2.29e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MTHFR—schizophrenia	5e-06	2.29e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—APOE—schizophrenia	4.99e-06	2.28e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—EP300—schizophrenia	4.99e-06	2.28e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—SNAP25—schizophrenia	4.96e-06	2.27e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP2D6—schizophrenia	4.96e-06	2.27e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—TH—schizophrenia	4.96e-06	2.27e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—APOA1—schizophrenia	4.93e-06	2.25e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—TH—schizophrenia	4.93e-06	2.25e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL1B—schizophrenia	4.92e-06	2.25e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—APOE—schizophrenia	4.91e-06	2.24e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ABCB1—schizophrenia	4.88e-06	2.23e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—APOA1—schizophrenia	4.85e-06	2.22e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP2D6—schizophrenia	4.85e-06	2.21e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—SNAP25—schizophrenia	4.85e-06	2.21e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—AKT1—schizophrenia	4.83e-06	2.21e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ESR1—schizophrenia	4.76e-06	2.18e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PLA2G4A—schizophrenia	4.74e-06	2.17e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GSTM1—schizophrenia	4.74e-06	2.17e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—APOE—schizophrenia	4.65e-06	2.13e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—APOA1—schizophrenia	4.6e-06	2.1e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TP53—schizophrenia	4.58e-06	2.09e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—AKT1—schizophrenia	4.56e-06	2.09e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—SNAP25—schizophrenia	4.53e-06	2.07e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP2D6—schizophrenia	4.53e-06	2.07e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP1A2—schizophrenia	4.49e-06	2.05e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—EP300—schizophrenia	4.43e-06	2.03e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—TH—schizophrenia	4.42e-06	2.02e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—EP300—schizophrenia	4.4e-06	2.01e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP1A2—schizophrenia	4.38e-06	2e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—AKT1—schizophrenia	4.38e-06	2e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—GSK3B—schizophrenia	4.32e-06	1.97e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—TH—schizophrenia	4.32e-06	1.97e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—COMT—schizophrenia	4.21e-06	1.93e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GSTP1—schizophrenia	4.2e-06	1.92e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—COMT—schizophrenia	4.19e-06	1.92e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—MTHFR—schizophrenia	4.19e-06	1.91e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—MAOA—schizophrenia	4.19e-06	1.91e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GSTP1—schizophrenia	4.17e-06	1.91e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—MAOA—schizophrenia	4.16e-06	1.9e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP1A2—schizophrenia	4.09e-06	1.87e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TP53—schizophrenia	4.09e-06	1.87e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TP53—schizophrenia	4.09e-06	1.87e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—EP300—schizophrenia	4.06e-06	1.85e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—EP300—schizophrenia	4.04e-06	1.84e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—TH—schizophrenia	4.03e-06	1.84e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—GSK3B—schizophrenia	4.03e-06	1.84e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ABCB1—schizophrenia	3.97e-06	1.81e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ABCB1—schizophrenia	3.95e-06	1.8e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—APOE—schizophrenia	3.9e-06	1.78e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—AKT1—schizophrenia	3.87e-06	1.77e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GSTM1—schizophrenia	3.86e-06	1.76e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PLA2G4A—schizophrenia	3.86e-06	1.76e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—APOA1—schizophrenia	3.85e-06	1.76e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GSTM1—schizophrenia	3.83e-06	1.75e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PLA2G4A—schizophrenia	3.83e-06	1.75e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—AKT1—schizophrenia	3.82e-06	1.75e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—COMT—schizophrenia	3.76e-06	1.72e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GSTP1—schizophrenia	3.74e-06	1.71e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—MAOA—schizophrenia	3.74e-06	1.71e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—COMT—schizophrenia	3.67e-06	1.68e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GSTP1—schizophrenia	3.65e-06	1.67e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—MAOA—schizophrenia	3.65e-06	1.67e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—EP300—schizophrenia	3.62e-06	1.66e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ABCB1—schizophrenia	3.54e-06	1.62e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—AKT1—schizophrenia	3.46e-06	1.58e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—AKT1—schizophrenia	3.46e-06	1.58e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GSTM1—schizophrenia	3.44e-06	1.57e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PLA2G4A—schizophrenia	3.44e-06	1.57e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—COMT—schizophrenia	3.43e-06	1.57e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GSTP1—schizophrenia	3.41e-06	1.56e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—MTHFR—schizophrenia	3.41e-06	1.56e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—MAOA—schizophrenia	3.41e-06	1.56e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—MTHFR—schizophrenia	3.39e-06	1.55e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PLA2G4A—schizophrenia	3.36e-06	1.53e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GSTM1—schizophrenia	3.36e-06	1.53e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—EP300—schizophrenia	3.3e-06	1.51e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ABCB1—schizophrenia	3.23e-06	1.48e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TP53—schizophrenia	3.17e-06	1.45e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—APOE—schizophrenia	3.17e-06	1.45e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—APOE—schizophrenia	3.15e-06	1.44e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PLA2G4A—schizophrenia	3.14e-06	1.43e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GSTM1—schizophrenia	3.14e-06	1.43e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—APOA1—schizophrenia	3.14e-06	1.43e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—APOA1—schizophrenia	3.12e-06	1.42e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—MTHFR—schizophrenia	3.04e-06	1.39e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—MTHFR—schizophrenia	2.97e-06	1.36e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—EP300—schizophrenia	2.84e-06	1.3e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—APOE—schizophrenia	2.83e-06	1.29e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—APOA1—schizophrenia	2.8e-06	1.28e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—EP300—schizophrenia	2.8e-06	1.28e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—MTHFR—schizophrenia	2.77e-06	1.27e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—APOE—schizophrenia	2.76e-06	1.26e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—APOA1—schizophrenia	2.73e-06	1.25e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—AKT1—schizophrenia	2.68e-06	1.22e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—AKT1—schizophrenia	2.66e-06	1.21e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—EP300—schizophrenia	2.65e-06	1.21e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—APOE—schizophrenia	2.58e-06	1.18e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—APOA1—schizophrenia	2.55e-06	1.17e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—EP300—schizophrenia	2.22e-06	1.02e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TP53—schizophrenia	2.03e-06	9.3e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—EP300—schizophrenia	1.81e-06	8.26e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—EP300—schizophrenia	1.8e-06	8.21e-06	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—AKT1—schizophrenia	1.72e-06	7.85e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—AKT1—schizophrenia	1.69e-06	7.73e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—EP300—schizophrenia	1.61e-06	7.37e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—AKT1—schizophrenia	1.6e-06	7.33e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—EP300—schizophrenia	1.57e-06	7.2e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—EP300—schizophrenia	1.47e-06	6.72e-06	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—AKT1—schizophrenia	1.34e-06	6.14e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—AKT1—schizophrenia	1.09e-06	4.99e-06	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—AKT1—schizophrenia	1.09e-06	4.96e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—AKT1—schizophrenia	9.75e-07	4.46e-06	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—AKT1—schizophrenia	9.52e-07	4.35e-06	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—AKT1—schizophrenia	8.89e-07	4.06e-06	CbGpPWpGaD
